VENOUS THROMBOEMBOLISM IN THAI CHILDREN

REFERENCES

• Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251–1257
   PubMed Web of Science ®Google Scholar
• Coon W W, Willis PW 3rd, Keller J B. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973; 48: 839–846
   PubMed Web of Science ®Google Scholar
• Gjores J E. The incidence of venous thrombosis and its sequelae in certain districts of Sweden. Acta Chir Scand 1956; 1–88
   Google Scholar
• Stein P D, Kayali F, Olson R E, Milford C E. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116: 435–442
   PubMed Web of Science ®Google Scholar
• White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4–I8
   PubMed Web of Science ®Google Scholar
• Cheuk B L, Cheung G C, Cheng S W. Epidemiology of venous thromboembolism in a Chinese population. Br J Surg 2004; 91: 424–428
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Prevalence of the C677T methylenetetra-hydrofolate reductase mutation in Thai patients with deep vein thrombosis. Acta Haematol 2000; 103: 191–196
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, et al. Prevalence of the G1691 A mutation in the factor V gene (factor V Leiden) and the G20210 A prothrombin gene mutation in the Thai population. Am J Hematol 2000; 65: 119–122
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Tardtong P, Hathirat P. Prevalence of factor V Leiden in Thai blood donors. J Med Assoc Thai 2001; 84: 489–493
   Google Scholar
• Klatsky A L, Baer D. What protects Asians from venous thromboembolism?. Am J Med 2004; 116: 493–495
   Google Scholar
• Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763–766
   PubMed Web of Science ®Google Scholar
• Visudhiphan S, Poolsuppasit S, Piboonnukarintr O, Tumliang S. The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais. Am J Clin Nutr 1982; 35: 1452–1458
   PubMed Web of Science ®Google Scholar
• Lee A C, Li C H, Szeto S C, Ma E S. Symptomatic venous thromboembolism in Hong Kong Chinese children. Hong Kong Med J 2003; 9: 259–262
   PubMedGoogle Scholar
• Brandt J T, Triplett D A, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–1190
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom H J, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113
   PubMed Web of Science ®Google Scholar
• Poort SR, Michiels J J, Reitsma P H, Bertina R M. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 1994; 72: 819–824
   Google Scholar
• Perry D J, Pasi K J. Resistance to activated protein C and factor V Leiden. QJM 1997; 90: 379–385
   Google Scholar
• Gerotziafas GT. Risk factors for venous thromboembolism in children. Int Angiol 2004; 23: 195–205
   Google Scholar
• Oren H, Devecioglu O, Ertem M, et al. Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol 2004; 21: 573–583
   PubMed Web of Science ®Google Scholar
• Kuhle S, Massicotte P, Chan A, et al. Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service. Thromb Haemost 2004; 92: 722–728
   PubMed Web of Science ®Google Scholar
• van Ommen C H, Heijboer H, Buller H R, Hirasing R A, Heijmans H S, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676–681
   PubMed Web of Science ®Google Scholar
• Anton N, Massicotte M P. Venous thromboembolism in pediatrics. Semin Vasc Med 2001; 1: 111–122
   Google Scholar
• Leroyer C, Mercier B, Oger E, et al. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998; 80: 49–51
   PubMed Web of Science ®Google Scholar
• Alhenc-Gelas M, Arnaud E, Nicaud V, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999; 81: 506–510
   PubMed Web of Science ®Google Scholar
• Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Ann Intern Med 1998; 129: 89–093
   PubMed Web of Science ®Google Scholar
• Garcia-Gala J M, Alvarez V, Pinto C R, et al. Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population. Clin Genet 1997; 52: 206–210
   PubMed Web of Science ®Google Scholar
• Ocal I T, Sadeghi A, Press R D. Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase. Mol Diagn 1997; 2: 61–68
   Google Scholar
• de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210 A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000; 110: 125–129
   Web of Science ®Google Scholar
• Ray J G, Langman L J, Vermeulen MJ, Evrovski J, Yeo EL, Cole DE. Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med 2001; 2: 141–149
   PubMedGoogle Scholar
• Franco R F, Araujo A G, Guerreiro J F, Elion J, Zago M A. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998; 79: 119–121
   PubMed Web of Science ®Google Scholar
• Gemmati D, Serino M L, Trivellato C, Fiorini S, Scapoli G L. C677T substitution in the methylene-tetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Haematologica 1999; 84: 824–828
   Google Scholar
• Koch H G, Nabel P, Junker R, et al. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis. Eur J Pediatr 1999; 158(Suppl 3)S113–S116
   Google Scholar
• Kosch A, Junker R, Kurnik K, et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 2000; 99: 531–537
   Google Scholar
• Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study). Blood Coagul Fibrinolysis 1998; 9: 71–78
   Google Scholar